Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherBEHAVIORAL PHARMACOLOGY

High-Affinity Benzodiazepine Antagonists Reduce Responding Maintained by Ethanol Presentation in Ethanol-Preferring Rats

Harry L. June, Dana Zuccarelli, Lucas Torres, Karen S. Craig, Jana Delong, Angela Allen, Misty R. Braun, Charity R. Cason and James M. Murphy
Journal of Pharmacology and Experimental Therapeutics March 1998, 284 (3) 1006-1014;
Harry L. June
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana Zuccarelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucas Torres
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen S. Craig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Delong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Allen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Misty R. Braun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charity R. Cason
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M. Murphy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In the present study, we examined two high-affinity and selective benzodiazepine (BDZ) receptor antagonists (ZK 93426, CGS 8216) in ethanol (EtOH)-preferring rats whose responding (i.e., lever pressing) was maintained by the presentation of EtOH. The in vivoactions of CGS 8216 (1–30 mg/kg) and ZK 93426 (5–75 mg/kg) were examined after intraperitoneal or oral administration. Flumazenil (10–40 mg/kg) was used as a reference BDZ antagonist. EtOH (10% v/v) and saccharin (0.05 g/v) solutions were concurrently available for 30 min each day under a two-lever fixed-ratio schedule in which four responses on one lever produced the EtOH solution and four responses on the other lever produced the saccharin solution. A 40 mg/kg intraperitoneal injection of flumazenil given on the first injection day (day 1) nonsignificantly reduced control levels of responding maintained by EtOH by 36%. No effects were observed 24 hr after drug administration (day 2). Oral administration of flumazenil was without effect. On day 1, intraperitoneal administration of CGS 8216 (1–20 mg/kg) and ZK 93426 (1–50 mg/kg) reduced control levels of responding maintained by EtOH by 44% to 73%; on day 2, EtOH maintained responding continued to be suppressed with the highest doses (≥20 mg/kg) suppressing control levels of responding by as much as 62%. Oral administration of higher doses of CGS 8216 (5–30 mg/kg) and ZK 93426 (10–75 mg/kg) reduced responding maintained by EtOH by as much as 54% to 84% of controls; however, no effects were seen on day 2. Only the highest intraperitoneal dose of ZK 93426 (50 mg/kg) suppressed responding maintained by saccharin. These findings demonstrate that some BDZ antagonists decrease responding maintained by EtOH. The findings suggest that certain BDZ antagonists may have potential as pharmacotherapies to prevent or decrease EtOH abuse in humans.

Footnotes

  • Send reprint requests to: Harry L. June, Ph.D., Department of Psychology, LD 124, IUPUI, 402 North Blackford Street, Indianapolis, IN 46202-3275. E-mail:hjune{at}iupui.edu

  • ↵1 This research was supported in part by Grants AA10717 and AA07611 from National Institute of Alcohal Abuse and Alcohalism. Portions of this research were presented in part at the Annual Meeting of the Research Society on Alcoholism, Washington, D.C., June 1996. D.Z. and L.T. were supported in part by the Indiana University-Purdue University, Indianapolis, Department of Psychology (SPUR) and Undergraduate Mentorship Fellowship from the Office of Faculty Development. L.T. and C.R.C. were supported in part by Grant T35 M from the National Heart, Lung, and Blood Institute, National Institutes of Health Training Program for Minority Students in Biomedical Research.

  • Abbreviations:
    EtOH
    ethanol
    BDZ
    benzodiazepine
    GABA
    γ-aminobutyric acid
    GABAA
    γ-aminobutyric acid type A
    P
    ethanol-preferring rats
    FR
    fixed-ratio
    ANOVA
    analysis of variance
    i.p.
    intraperitoneal
    BAC
    blood alcohol concentration
    • Received December 24, 1996.
    • Accepted November 28, 1997.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 284, Issue 3
1 Mar 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
High-Affinity Benzodiazepine Antagonists Reduce Responding Maintained by Ethanol Presentation in Ethanol-Preferring Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherBEHAVIORAL PHARMACOLOGY

High-Affinity Benzodiazepine Antagonists Reduce Responding Maintained by Ethanol Presentation in Ethanol-Preferring Rats

Harry L. June, Dana Zuccarelli, Lucas Torres, Karen S. Craig, Jana Delong, Angela Allen, Misty R. Braun, Charity R. Cason and James M. Murphy
Journal of Pharmacology and Experimental Therapeutics March 1, 1998, 284 (3) 1006-1014;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherBEHAVIORAL PHARMACOLOGY

High-Affinity Benzodiazepine Antagonists Reduce Responding Maintained by Ethanol Presentation in Ethanol-Preferring Rats

Harry L. June, Dana Zuccarelli, Lucas Torres, Karen S. Craig, Jana Delong, Angela Allen, Misty R. Braun, Charity R. Cason and James M. Murphy
Journal of Pharmacology and Experimental Therapeutics March 1, 1998, 284 (3) 1006-1014;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of residues S426 and S430 in cannabinoid tolerance
  • DAT ligands on Cocaine-Food Choice in Monkeys
  • MDPV high-responders to evaluate candidate medications
Show more Behavioral Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics